Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL gene rearrangement: Case report and review of the literature

Cancer Genetics and Cytogenetics

Volumn 138, Issue 2, 2002, Pages 139-142

  Keung, Yi Kong ^a,b   Beaty, Michael ^b   Steward, William ^b   Jackle, Bethy ^b   Pettnati, Mark ^b  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; ENDOCARDITIS; EOSINOPHILIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; HUMAN; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 9; EOSINOPHILIA; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PHILADELPHIA CHROMOSOME; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC;

EID: 0037110168     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00609-X     Document Type: Article

References (35)

1. Faderl S., Talpaz M., Estrov Z., O'Brien S., Kurzrock R., Kantarjian H.M. The biology of chronic myeloid leukemia. N Engl J Med. 341:1999;164-172.
2. McClure J.S., Litz C.E. Chronic myelogenous leukemia. molecular diagnostic considerations Hum Pathol. 25:1994;594-597.
3. Spiers A.S., Bain B.J., Turner J.E. The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases. Scand J Haematol. 18:1977;25-38.
4. Koeffler H.P., Levine A.M., Sparkes M., Sparkes R.S. Chronic myelocytic leukemia. eosinophils involved in the malignant clone Blood. 55:1980;1063-1065.
5. Stockdill G., Hartley S.E., Allan N.C. Eosinophilic leukaemia in association with a double Philadelphia chromosome. Postgrad Med J. 56:1980;268-270.
6. Marinone G., Rossi G., Verzura P. Eosinophilic blast crisis in a case of chronic myeloid leukaemia. Brit J Haematol. 55:1983;251-256.
7. Chan L.C., Kwong Y.L., Lie A.K., Ching L.M. A case of Philadelphia-negative, M-BCR rearranged eosinophilic leukemia with trisomy 8 localized by in situ hybridization. Leukemia. 8:1994;195-198.
8. Duell T., Mittermuller J., Schmetzer H.M., Kolb J.H., Wilmanns W. Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32). Cancer Genet Cytogenet. 94:1997;91-94.
9. Lee M.S., LeMaistre A., Kantarjian H.M., Talpaz M., Freireich E.J., Trujillo J.M., Stass S.A. Detection of two alternative BRC/ABL mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Blood. 73:1989;2165-2170.
10. Papadopoulos P., Ridge S.A., Boucher C.A., Stocking C., Widemann L.M. The novel activation of ABL by fusion to an ETS-related gene, TEL. Cancer Res. 55:1995;34-38.
11. Golub T.R., Goga A., Barker G.F., Afar D.E., McLaughlin J., Bohlander S.K., Rowley J.D., Witte O.N., Gilliland D.G. Oligomerization of the ABL tyrosine kinase by the ETS protein TEL in human leukemia. Mol Cell Biol. 16:1996;4107-4116.
12. Brunel V., Sainty D., Carbuccia N., Mozziconacci M., Fernandez F., Simonetti J., Gabert J., Dubreuil P., Lafage-Pochitaloff M., Birg F. A TEL/ABL fusion gene on chromosome 12p13 in a case of Ph-, BCR-atypical CML. Leukemia. 10:1996;2003.
13. Andreasson P., Johansson B., Carlsson M., Jarlsfelt I., Fioretos T., Mitelman F., Hoglund M. BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion. Genes Chromosom Cancer. 20:1997;299-304.
14. Van Limbergen H., Beverloo H.B., van Drunen E., Janssens A., Hahlen K., Poppe B., Van Roy N., Marynen P., De Paepe A., Slater R., Speleman F. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia. Genes Chromosom Cancer. 30:2001;274-282.
15. Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGF receptor beta to novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 77:1994;307-316.
16. Buijs A., Sherr S., van Baal S., van Bezouw S., van der Plas D., Geurts van Kessel A., Riegman P., Lekanne Dr Zwarthoff E., Hagemeijer A. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene. 10:1995;1511-1519.
17. Peeters P., Wlodarska I., Baens M., Criel A., Selleslag D., Hagemeijer A., Van Den Berghe H., Marynen P. Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Cancer Res. 57:1997;564-569.
18. Romana S.P., Mauchauffe M., Le Coniat M., Chumakov I., Le Paslier D., Berger R., Bernard O.A. The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood. 85:1995;3662-3670.
19. Wlodarska I., La Starza R., Baens M., Dierlamm J., Uyttebroeck A., Selleslag D., Francine A., Mecucci C., Hagemeijer A., Van Den Berghe H., Marynen P. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. Blood. 91:1998;1399-1406.
20. Rowley J.D. The role of chromosome translocations in leukemogenesis. Semin Hematol. 36(Suppl 7):1999;59-72.
21. Yagasaki F., Jinnai I., Yoshida S., Yokoyama Y., Matsuda A., Kusumoto S., Kobayashi H., Terasaki H., Ohyashiki K., Asou N., Murohashi I., Bessho M., Hirashima K. Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q13;p13). Genes Chromosom Cancer. 26:1999;192-202.
22. Salomon-Nguyen F., Della-Valle V., Mauchauffe M., Busson-Le Coniat M., Ghysdael J., Berger R., Bernard O.A. The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion. Proc Natl Acad Sci USA. 97:2000;6757-6762.
23. Nakamura Y., Nakazato H., Sato Y., Furusawa S., Mitani K. Expression of the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13). Am J Hematol. 69:2002;80-82.
24. BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. Oncogene. 13:1996;1147-1152.
25. Voss J., Posern G., Hannemann J.R., Wiedemann L.M., Turhan A.G., Poirel H., Bernard O.A., Adermann K., Kardinal C., Feller S.M. The leukaemic oncoproteins BCR-ABL and TEL-ABL (ETV6/ABL) have altered substrate preferences and activate similar intracellular signalling pathways. Oncogene. 19:2000;1684-1690.
26. Keene P., Mendelow B., Pinto M.R., Bezwoda W., MacDougall L., Falkson G., Ruff P., Bernstein R. Abnormalities of chromosome 12p13 and malignant proliferation of eosinophils. a nonrandom association Brit J Haematol. 67:1987;25-31.
27. Yahata N., Ohyashiki K., Ohyashiki J.H., Kimura Y., Miyazawa K., Kodama A., Fukutake K., Toyamja K. Late appearance of t(5;12)(q31;p12) in acute myeloid leukemia associated with eosinophilia. Cancer Genet Cytogenet. 107:1998;147-150.
28. Srivastava A., Boswell H.S., Heerema N.A., Nahreini P., Lauer R.C., Antony A.C., Hoffman R., Tricot G.J. KRAS2 oncogene overexpression in myelodysplastic syndrome with translocation 5;12. Cancer Genet Cytogenet. 35:1988;61-71.
29. Berkowicz M., Rosner E., Rechavi G., Mamon Z., Neuman Y., Ben Bassat I., Ramot B. Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12). A new association. Cancer Genet Cytogenet. 51:1991;277-278.
30. Jani K., Kempski H.M., Reeves B.R. A case of myelodysplasia with eosinophilia having a translocation t(5;12)(q31;q13) restricted to myeloid cells but not involving eosinophils. Brit J Haematol. 87:1994;57-60.
31. Pellier I., Le Moine P.J., Rialland X., Francois S., Baranger L., Blanchet O., Larget-Piet L., Ifrah N. Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia. a pediatric case with review of literature J Ped Hematol Oncol. 18:1996;285-288.
32. Wessels J.W., Fibbe W.E., van der Keur D., Landegent J.E., van der Plas D., ven Ottolander G.J., Roozendaal K.J., Beverstock G.C. t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Cancer Genet Cytogenet. 65:1993;7-11.
33. Gotic M., Radosevic-Radojkovic N., Ludoski M., Spasoc P., Basara N., Avramovic D., Boskovic D., Rolovic Z. Eosinophilic leukemia with chromosomal aberration t(5;12)(q31;q13). Br J Haematol. 87(Suppl 1):1994;168.
34. Baranger L., Szapiro N., Gardais J., Hillion J., Derre J., Francois S., Blanchet O., Boasson M., Berger R. Translocation t(5;12)(q31-q33;p12-p12). a non-random translocation associated with a myeloid disorder with eosinophilia Brit J Haematol. 88:1994;343-347.
35. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH Conference. The idiopathic hyperosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Int Med 1982;87:78-92.